As fitness increases, risk of cardiovascular disease (CVD) may decrease regardless of genetic predisposition, according to new findings published in Circulation on April 9.

AUSTIN, Texas, April 12, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced an additional analysis from the landmark CANVAS Program showing INVOKANA® (canagliflozin) improved renal outcomes in people with type 2 diabetes mellitus with or at high risk for cardiovascular disease.

A report issued by the Institute for Patient Access suggests commercial healthcare insurance plans, as well as Medicare, Medicaid and Medicaid managed care, denied coverage for almost 80,000 insurance claims for PCSK9 inhibitors in 2017.

To mitigate the obesity epidemic, increase workplace productivity and reduce absences, employers across the United States are engaging in employee-wide wellness programs.

Elevated blood pressure before pregnancy may increase the risk for miscarriage, according to findings published April 2 in Hypertension. This proves true for women who exhibit high blood pressure preconception but have not been diagnosed with hypertension.

Fish oil supplements shouldn’t be considered equivalent to omega-3 products that have undergone strict clinical testing and FDA oversight, said biochemist Preston Mason, PhD. The first group of products could be harmful to patients with cardiovascular disease, while more refined compounds might help.

People are more likely to prefer a daily cup of tea or a pill over exercise as a treatment options for high blood pressure, according to findings of a survey presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018 in Arlington, Virginia.

Hypertension, elevated cholesterol and hearing difficulty are more prevalent among noise‐exposed workers, according to new research led by the Centers for Disease Control and Prevention (CDC)’s National Institute for Occupational Safety and Health (NIOSH).